Karyopharm Therapeutics Cash Flow Statement (2012-2025) | KPTI

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter)
-57.41M-53.58M-51.81M68.74M-41.40M-49.06M-36.32M-38.54M-34.13M-32.63M-34.51M101.19M-37.36M23.79M-32.07M-30.86M-23.46M-37.25M-33.13M90.19M
Depreciation and Depletion (Quarter)
0.23M0.23M0.19M0.14M0.18M0.15M0.18M0.11M0.29M0.08M0.08M0.08M0.09M0.09M0.08M0.08M0.08M0.08M0.12M0.02M
Share-based Compensation (Quarter)
7.36M8.13M7.42M6.87M7.34M15.09M6.80M6.17M5.39M6.06M5.08M5.18M5.41M5.41M4.18M3.86M3.78M3.56M2.80M3.90M
Gains from Sales and Divestitures (Quarter)
0.48M957.73M1.05M2.44M0.23M
Gains from Investment Securities (Quarter)
-0.23M0.16M0.18M0.00M0.00M-0.00M-0.00M-0.00M0.00M0.00M0.43M0.04M
Asset Writedowns and Impairment (Quarter)
0.08M0.10M0.20M
Non-cash Items (Quarter)
2.29M0.01M0.21M
Cash from Operations (Quarter)
-52.89M-55.75M-23.95M25.48M-59.20M-35.14M-28.37M-26.84M-18.91M-25.70M-29.53M-18.59M-43.73M-38.50M-19.45M-25.81M-38.98M-18.70M-5.86M-11.83M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.66M-0.48M-0.27M-0.14M-0.04M0.12M0.29M0.46M1.13M1.01M0.94M1.02M0.91M0.67M0.53M0.39M0.24M0.12M0.04M0.01M
Amortization of Deferred Charges (Quarter)
0.19M0.20M0.20M0.20M0.20M0.20M0.20M0.21M0.20M0.19M0.20M0.22M0.21M1.40M2.41M2.36M2.57M2.72M2.81M2.44M
Depreciation & Amortization (CF) (Quarter)
0.23M0.23M0.19M0.14M0.18M0.15M0.18M0.11M0.29M0.08M0.08M0.08M0.09M0.09M0.08M0.08M0.08M0.08M0.12M0.02M
Change in Working Capital
Change in Receivables (Quarter)
4.96M0.04M0.86M3.75M2.50M-1.51M3.97M0.14M-11.89M-2.92M5.64M-10.96M4.12M6.91M-6.22M-1.01M4.48M-2.31M-1.05M-5.70M
Change in Inventory (Quarter)
0.55M0.95M-0.12M0.08M-0.23M-0.40M0.78M-0.03M-0.40M-0.15M-0.57M-0.06M-0.27M0.71M1.20M0.07M0.03M0.22M-1.03M0.07M
Change in Account Payables (Quarter)
-1.41M-0.73M-1.43M0.72M1.84M-1.75M-0.88M1.96M6.27M-6.76M-1.34M2.18M1.91M-2.23M2.99M-0.68M0.77M-3.27M2.79M-1.39M
Change in Accured Expenses (Quarter)
3.43M-3.24M12.09M3.68M-9.39M-2.18M-0.05M2.08M-9.41M5.34M3.30M4.78M-4.86M0.06M2.55M6.45M-0.41M8.58M9.45M1.44M
Other Working Capital Changes (Quarter)
-0.30M-1.11M26.16M15.60M-0.74M-16.51M7.43M-1.54M-0.19M-3.89M2.74M-0.79M-0.81M-0.83M3.48M-1.96M-2.04M-0.22M3.78M
Investing Activities
Capital Expenditures (Quarter)
0.01M0.21M0.08M0.04M0.20M-0.05M
Change in Acquisitions & Divestments (Quarter)
68.95M55.43M37.93M30.48M21.58M26.88M41.61M31.80M27.94M57.36M38.38M43.40M53.74M56.16M28.28M16.25M15.29M18.29M4.80M5.00M
Cash from Investing Activities (Quarter)
43.19M46.46M21.43M30.77M-14.04M-36.60M11.67M-65.30M-32.39M21.17M-7.68M26.84M21.94M51.26M7.47M14.80M15.29M18.29M4.80M5.00M
Financing Activities
Other financing activities (Quarter)
Cash from Financing Activities (Quarter)
10.68M62.06M0.02M0.90M30.78M1.31M5.80M155.84M0.86M0.26M0.68M29.69M
Additional items
Exchange Rate Effect (Quarter)
-0.09M-0.06M0.24M-0.14M-0.09M-0.45M-0.07M0.13M-0.04M-0.03M-0.05M0.09M-0.02M-0.01M0.04M-0.02M0.01M0.01M0.00M0.01M
Change in Cash (Quarter)
0.88M52.71M-2.27M57.01M-42.54M-70.88M-10.97M63.83M-51.34M-3.69M-37.27M8.61M-21.80M53.72M-11.94M-10.35M-23.69M-0.05M-1.05M22.87M
Free Cash Flow (Quarter)
-52.89M-55.75M-23.96M25.27M-59.28M-35.14M-28.41M-26.84M-18.91M-25.70M-29.53M-18.59M-43.92M-38.50M-19.45M-25.76M-38.98M-18.70M-5.86M-11.83M
Net Cash Flow (Quarter)
0.97M52.77M-2.51M57.14M-42.45M-70.43M-10.90M63.70M-51.30M-3.67M-37.22M8.52M-21.79M12.76M-11.98M-10.33M-23.70M-0.41M-1.05M22.86M